Dmitry Martynenko
Director/Miembro de la Junta en Novicol International Holding, Inc. .
Origen de la red de primer grado Dmitry Martynenko.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Novicol International Holding, Inc.
1
| Private Company | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Dmitry Martynenko a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cantex Pharmaceuticals, Inc.
 Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL. | Pharmaceuticals: Major | President | |
| RENOVARO INC. | Biotechnology | Chief Executive Officer | |
| BIOHEMP INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
| University of Grenoble | College/University | Doctorate Degree | |
| Institut Supérieur des Affaires | College/University | Masters Business Admin | |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Dandrit Corp. Pte Ltd. | Chief Executive Officer | ||
Immunethep SA
 Immunethep SA BiotechnologyHealth Technology Immunethep SA develops biological products. It specializes in anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. The company was founded by Pedro Madureira and Bruno Santos and is headquartered in Cantanhede, Portugal. | Biotechnology | Director/Board Member | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Aids Initiative | Corporate Officer/Principal | ||
Inhatarget Therapeutics
 Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer. | Pharmaceuticals: Major | Director/Board Member | |
| GENFLOW BIOSCIENCES PLC | Biotechnology | Founder | |
| Bsim Therapeutics Ltd. | Director/Board Member | ||
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 10 |
| Francia | 6 |
| Canadá | 3 |
| Reino Unido | 3 |
| Dinamarca | 3 |
Sectorial
| Health Technology | 17 |
| Consumer Services | 5 |
| Finance | 2 |
| Miscellaneous | 2 |
| Commercial Services | 2 |
Operativa
| Director/Board Member | 16 |
| Chief Executive Officer | 8 |
| Corporate Officer/Principal | 6 |
| Masters Business Admin | 3 |
| President | 3 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Eric Jean Marie Leire | 28 |
- Bolsa de valores
- Insiders
- Dmitry Martynenko
- Conexiones Empresas
